Published online Nov 6, 2021. doi: 10.12998/wjcc.v9.i31.9440
Peer-review started: March 15, 2021
First decision: April 4, 2021
Revised: April 15, 2021
Accepted: September 29, 2021
Article in press: September 29, 2021
Published online: November 6, 2021
Processing time: 228 Days and 8.7 Hours
The identification of risk factors for recurrence in patients with minor ischemic stroke (MIS) is a critical medical need.
To develop a nomogram for individualized prediction of in-hospital recurrence in MIS patients.
To develop a nomogram for individualized prediction of in-hospital recurrence in MIS patients.
The predictive accuracy of a nomogram model to predict the probability of unfavorable outcome was assessed by calculation of the area under the receiver operating characteristic curve (AUC-ROC). Calibration of the risk prediction model was assessed by a plot comparing the observed probability of unfavorable outcome against the predicted, and by using the Hosmer–Lemeshow test.
A total of 2216 MIS patients were screened. Among them, 155 were excluded for intravascular therapy, 146 for unknown National Institutes of Health Stroke Scale (NIHSS) score, 424 for intracranial hemorrhage, and 247 for progressive stroke. Finally, 1244 patients were subjected for further analysis and divided into a training set (n = 796) and a validation set (n = 448). Multivariate logistic regression analysis revealed that uric acid [odds ratio (OR): 0.997, 95% confidence interval (CI): 0.993-0.999], ferritin (OR: 1.004, 95%CI: 1.002-1.006), and serum total bilirubin (OR: 0.973, 95%CI: 0.956-0.990) were independently associated with in-hospital recurrence in MIS patients. Our model showed good discrimination; the AUC-ROC value was 0.725 (95%CI: 0.646-0.804) in the training set and 0.717 (95%CI: 0.580-0.785) in the validation set. Moreover, the calibration between nomogram prediction and the actual observation showed good consistency. Hosmer-Lemeshow test results confirmed that the nomogram was well-calibrated (P = 0.850).
This study has developed and verified that the nomogram can provide individualized, intuitive, and accurate prediction for the recurrence of mild ischemic stroke inpatients in China.
Our present findings suggest that the nomogram may provide individualized prediction of recurrence in MIS patients.